An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
Status:
Withdrawn
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of BPS804 on strength/quality of bone
in patients with Type I, III or IV Osteogenesis imperfecta using a special type of CT
scanner. Participants will be treated for 1 year.